Table 3.

Summary of mutations in HIV-1 pro and RT for which significant correlations were found between community drug resistance (CDR) weighted for individual viral loads and transmitted drug resistance (TDR) measurements; p values were calculated with Spearman ranked correlation coefficient.

Mutation	Rho (p-value)	Measurement Interval
I54V,L,M,A,T,S (pro)	−0.05 (0.87)	Yearly
	0.20 (0.40)	Every 6 months
	0.38 (0.040)	Every 4 months
	0.24 (0.154)	Every 3 months
V82A,T,F,S,C,M,L (pro)	−0.46 (0.154)	Yearly
	−0.56 (0.013)	Every 6 months
	−0.16 (0.41)	Every 4 months
	−0.26 (0.115)	Every 3 months
D67N,G,E (RT)	−0.21 (0.54)	Yearly
	0.22 (0.37)	Every 6 months
	0.40 (0.032)	Every 4 months
	0.38 (0.019)	Every 3 months
K103N,S (RT)	0.76 (0.009)	Yearly
	0.40 (0.091)	Every 6 months
	0.39 (0.037)	Every 4 months
	0.19 (0.26)	Every 3 months
G190A,S,E (RT)	−0.68 (0.022)	Yearly
	−0.24 (0.32)	Every 6 months
	−0.08 (0.70)	Every 4 months
	0.03 (0.87)	Every 3 months